Company
ATXA THERAPEUTICS
- Biotech
- Founded:
- 2015
- Headquarters:
- Dublin, Ireland
- Location:
- Dublin (Dublin, Ireland)
Description
ATXA THERAPEUTICS develops selective small-molecule thromboxane receptor (TP) antagonists and clinical candidate NTP42 for cardiopulmonary diseases, targeting pulmonary arterial hypertension and related indications for clinicians and patients.